BMJ · 2012 · 29 citations · 2 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyDrug InformationPsychopharmacologyAdverse Drug Event ReportingAdverse Drug Reaction ReportingInvestigational New Drug ApplicationsPharmacoepidemiologyRegulatory PharmacologySpontaneous Reporting SystemsClinical Pharmacology EvidenceDrug Information BiasMedical Journal AdvertisingMisleading Drug AdvertisingOff-label Drug Use EvidenceSelective Reporting BiasSelective Reporting PoliciesSuspected Adverse Drug Reaction Reporting
In the first of a new occasional series highlighting the exaggerations, distortions, and selective reporting that make some news stories, advertising, and medical journal articles “not so,” <b>Lisa M Schwartz</b> and <b>Steven Woloshin</b> challenge the claims made for the new 23 mg dose of donepezil
2
Martin R. Farlow, Stephen Salloway, Pierre N. Tariot et al. · Clinical Therapeutics · 2010 · 214 citations